Answers are grounded in this paper and cite their sources.
Discusses the difficulties and uncertainties in evaluating the incidence of rare diseases like CTEPH, referencing a meta-analysis by Ende-Verhaar et al.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonary hypertension, classified as group 4 in the present clinical classification [1, 2]. CTEPH is generally considered a late complication of one or multiple episodes of acute pulmonary embolism that have not resolved despite at least 3 months of therapeutic anticoagulation. Haemodynamically, CTEPH is characterised by a mean pulmonary arterial pressure of at least 25 mmHg at rest, measured during right heart catheterisation. The meta-analysis by Ende-Verhaar et al. provides important information and helps guide clinical practice in CTEPH <http://ow.ly/Are8307RTPx>
No takes yet. Share an insight, caveat, or question.
Simonneau et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: